Skip to main content
Genix Pharmaceuticals Corporation (TSXV:GENX)
Canada flag Canada · Delayed Price · Currency is CAD
0.0200
0.00 (0.00%)
Apr 28, 2026, 9:30 AM EST

Genix Pharmaceuticals Cash Flow Statement

Millions CAD. Fiscal year is Nov - Oct.
Fiscal Year
 TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
 Jan '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21 2020 - 2016
Net Income
-0.28-0.34-0.07-4.4-1.07-1.65
Upgrade
Depreciation & Amortization
---0.550.560.54
Upgrade
Other Amortization
000000
Upgrade
Asset Writedown & Restructuring Costs
0.010.01-3.46--
Upgrade
Stock-Based Compensation
--0.030.060.260.81
Upgrade
Other Operating Activities
0.150.17-0.170.060.040
Upgrade
Change in Accounts Receivable
00-00.02-0.010
Upgrade
Change in Inventory
---00.01-0.17-0
Upgrade
Change in Accounts Payable
0.010.010.040.030.18-0.09
Upgrade
Change in Other Net Operating Assets
0.020.02-0-0-0-0.03
Upgrade
Operating Cash Flow
-0.09-0.12-0.19-0.22-0.22-0.43
Upgrade
Sale (Purchase) of Intangibles
-----0-
Upgrade
Investing Cash Flow
-----0-
Upgrade
Short-Term Debt Issued
-0.090.190.280.17-
Upgrade
Total Debt Issued
0.030.090.190.280.17-
Upgrade
Long-Term Debt Repaid
--0.03---0.02-0.01
Upgrade
Total Debt Repaid
-0.03-0.03---0.02-0.01
Upgrade
Net Debt Issued (Repaid)
00.060.190.280.15-0.01
Upgrade
Issuance of Common Stock
0.10.1----
Upgrade
Other Financing Activities
-0-0--0.06-0.05-0.12
Upgrade
Financing Cash Flow
0.10.160.190.220.09-0.13
Upgrade
Net Cash Flow
0.010.03-00-0.13-0.56
Upgrade
Free Cash Flow
-0.09-0.12-0.19-0.22-0.22-0.43
Upgrade
Free Cash Flow Margin
---4624.54%-1787.27%--
Upgrade
Free Cash Flow Per Share
-0.00-0.00-0.00-0.00-0.00-0.01
Upgrade
Cash Interest Paid
----0-
Upgrade
Levered Free Cash Flow
-0.17-0.15-0.530.060.170.68
Upgrade
Unlevered Free Cash Flow
-0.06-0.04-0.460.090.180.68
Upgrade
Change in Working Capital
0.030.030.030.06-0.01-0.12
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.